Michal Drayman

Jerusalem Venture Partners (JVP) thesis

JVP led 45 of the most significant IPOs and M&As out of Israel, New York, and Europe JVP was a Round A investor in CyberArk (NASDAQ: CYBR), growing the company into a multibillion-dollar leader in identity security and privileged access management, protecting against the “enemy from within.” After investing early, JVP doubled down with a significant secondary transaction alongside Goldman Sachs, ultimately reaching 47% ownership and leading the company to a NASDAQ IPO under JP Morgan. In July 2025, CyberArk—now one of the world’s leading cyber companies—was acquired by Palo Alto Networks for $

Sector and stage focus

• Seed: Medical Devices, Health IT, Digital Health, FinTech, Health & Hospital Services
• Series B: Medical Devices, FinTech, Health & Hospital Services, Digital Health, Health IT
• Series A: Medical Devices, Health IT, Health & Hospital Services, FinTech, Digital Health
• general: Israel

Is Michal Drayman a fit for your round?

Upload your pitch deck and see whether Michal Drayman appears in your top 20 matches.